Media Mosiac Gov Solutions Book a Strategy Call
Gov.MediaMosiac › GovCon News
🏛 GovCon Intel Opportunities Presolicitations Contract Awards Award Notices Grants Events Regulatory Search 📝 Insights
← Back to Federal Grants
RFA-CA-28-002

Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

Federal Grant Forecasted Active
RFA-CA-28-002
National Institutes of Health
Forecasted
$0
Active

📄 Description

Opportunity #: RFA-CA-28-002. Agency: National Institutes of Health. Status: Forecasted Posted: 07/14/2026.
🔍 Search on Grants.gov → 🏛 View on SAM.gov (CFDA) More from this Agency
Program #: RFA-CA-28-002 • Added: Jul 14, 2026 11:27 AM

Program Info

$0
Total Funding
CFDA #RFA-CA-28-002
TypeForecasted
StatusActive

Related Programs

Causal Hypotheses on the Oral-Systemic Health Impacts of Hu…
PAR-27-057 • $0
Ruth L. Kirschstein National Research Service Award (NRSA) …
PA-25-424 • $0
Molecular Imaging of Inflammation in Cancer (R01 Clinical T…
PAR-24-311 • $0
Elucidation and Validation of the role of Transporters in t…
RFA-HD-28-003 • $0
🎯 Get GovCon Intel Free →